Nasal Alzheimer’s drug effective regardless of brain plaque levels

Researchers have found that an intranasal immunotherapy drug, currently being tested as a treatment for multiple sclerosis, reduced brain inflammation and improved cognition in mice with Alzheimer’s disease, independent of the amount of beta-amyloid plaques present. They say the treatment could benefit people in the later stages of the disease. Continue Reading Category: Medical, Science Tags: Alzheimer's Disease, Brain, Inflammatory, antibodies, Brigham and Women’s Hospital
http://dlvr.it/SwG0Yd